« previous next »
Pages: [1]

Author Topic: More skin cancer reported to FDA from patients on certain oral DMTs  (Read 37 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
More skin cancer reported to FDA from patients on certain oral DMTs
« on: February 24, 2022, 04:21:07 pm »
From Multiple Sclerosis News Today (February 22, 2022)--"More Skin  Cancer Reported to FDA from Patients on Certain Oral DMTs":




https://bit.ly/3sgMJr6


Mayzent (siponimod) and Gilenya (fingolimod) were the drugs where there was the most noticeable increase in skin cancer but several other MS drugs showed an increase as well.


The article contains a statement that is worth noting:


Quote
However, “evidence is insufficient to support a causative link,” the researchers wrote.

Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
1 Replies
249 Views 		Last post October 25, 2016, 09:09:15 am
by agate
0 Replies
140 Views 		Last post May 16, 2017, 12:21:07 pm
by agate
0 Replies
33 Views 		Last post June 05, 2020, 08:09:00 pm
by agate
0 Replies
38 Views 		Last post February 24, 2022, 04:23:57 pm
by agate
0 Replies
34 Views 		Last post March 02, 2022, 09:48:32 pm
by agate